It is hard give a price target post anchor model, yes there would be expansion. But i think its more about sentiment in the short run and sales or BO in the long run. The anchor results will create a positive sentiment and push up the price in the short run. Until detailed results come out, I cant say how the target price will change and therefore cant really Quantify the long term affect.
Yes are right to some extent, but this is not totally a best case scenario, but yes stuff can go wrong. I plan to write a report on all the downside risks to Amarin soon. About Vascepa being better than Lovaza, that's a slam dunk thing and at the end of the day mate, it comes down to trusting the management. I trust Amarin's management because I believe their past record deserves trust. Cheers
Buy Amarin: Acquisition Prospects Just Got Better [View article]
Hi Yazzbro, If we put speculation aside, and I do not want to speculate at this stage. I think very highly of him and I believe he will be an asset to AMRN and a person of his capability joining the board should be positive news for investors.
Is There Still Hope For Teva Investors? [View article]
@Frank Yes I have no other information than is publicly available. the revenue figures above are past figures, taken from statements. Can you please point out the error, so i can correct it?
Just look at past perfomance of TEVA, tell me why the future should be different?
Pfizer - Old Company, Exciting New Catalysts [View article]
Shikes, I don't see any solid catalyst for a pullback in the short run, the fiscal cliff doesn't affect pfizer like it affects other companies e.g. consumer.
Pfizer - Old Company, Exciting New Catalysts [View article]
Buy Amarin: Acquisition Prospects Just Got Better [View article]
An Excellent Biotech Bet For 2013 [View article]
Buy Amarin: Huge Upside Despite Commercialization Efforts [View article]
Buy Amarin: Huge Upside Despite Commercialization Efforts [View article]
Buy Amarin: Acquisition Prospects Just Got Better [View article]
Is There Still Hope For Teva Investors? [View article]
Yes I have no other information than is publicly available. the revenue figures above are past figures, taken from statements. Can you please point out the error, so i can correct it?
Just look at past perfomance of TEVA, tell me why the future should be different?
Pfizer - Old Company, Exciting New Catalysts [View article]
Pfizer - Old Company, Exciting New Catalysts [View article]
Pfizer - Old Company, Exciting New Catalysts [View article]
Investors To Benefit From Apollo Residential Mortgage's 15.6% Dividend Yield [View article]
Buy MAP Pharmaceutical For 70% Upside [View article]
Annaly Capital Vs. American Capital Going Into 2013 [View article]
Is Vale The Top Iron Ore Stock For 2013? [View article]
Thanks
An Excellent Biotech Bet For 2013 [View article]